JP2024512418A5 - - Google Patents
Info
- Publication number
- JP2024512418A5 JP2024512418A5 JP2023555563A JP2023555563A JP2024512418A5 JP 2024512418 A5 JP2024512418 A5 JP 2024512418A5 JP 2023555563 A JP2023555563 A JP 2023555563A JP 2023555563 A JP2023555563 A JP 2023555563A JP 2024512418 A5 JP2024512418 A5 JP 2024512418A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210042305 | 2021-03-31 | ||
| KR10-2021-0042305 | 2021-03-31 | ||
| PCT/KR2022/004620 WO2022211537A1 (ko) | 2021-03-31 | 2022-03-31 | 신규한 면역 활성 인터루킨 2 아날로그 결합체 및 이의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512418A JP2024512418A (ja) | 2024-03-19 |
| JP2024512418A5 true JP2024512418A5 (enExample) | 2025-04-10 |
Family
ID=83459706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555563A Pending JP2024512418A (ja) | 2021-03-31 | 2022-03-31 | 新規な免疫活性インターロイキン２アナログ結合体及びその製造方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US12599675B2 (enExample) |
| EP (1) | EP4316528A4 (enExample) |
| JP (1) | JP2024512418A (enExample) |
| KR (2) | KR102680146B1 (enExample) |
| CN (1) | CN116916969A (enExample) |
| AR (1) | AR125263A1 (enExample) |
| AU (1) | AU2022209248B2 (enExample) |
| BR (1) | BR112023018530A2 (enExample) |
| CA (1) | CA3205058C (enExample) |
| CL (1) | CL2023002504A1 (enExample) |
| IL (1) | IL304365B2 (enExample) |
| MX (1) | MX2023010926A (enExample) |
| PE (1) | PE20250672A1 (enExample) |
| TW (1) | TWI922649B (enExample) |
| WO (1) | WO2022211537A1 (enExample) |
| ZA (1) | ZA202307219B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7819944B2 (ja) * | 2020-07-09 | 2026-02-25 | ユーティレックス カンパニー リミテッド | Ｉｌ－２バリアント |
| EP4640210A1 (en) | 2022-12-23 | 2025-10-29 | Hanmi Pharm. Co., Ltd. | Formulation containing immunoactive interleukin 2 analog conjugate |
| TW202502372A (zh) * | 2023-03-07 | 2025-01-16 | 南韓商韓美藥品股份有限公司 | 包含ｉｌ－２類似物或其接合物之用於預防或治療癌症之醫藥組成物 |
| TW202525327A (zh) * | 2023-03-07 | 2025-07-01 | 南韓商韓美藥品股份有限公司 | Ｉｌ－２類似物或其接合物與免疫檢查點抑制劑用於預防或治療癌症的組合療法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| CA2249195A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| KR100507796B1 (ko) * | 2003-04-03 | 2005-08-17 | 한미약품 주식회사 | 생체내 반감기가 증가된 ｐｅｇ-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법 |
| CN105440123B (zh) * | 2011-02-10 | 2020-10-09 | 罗切格利卡特公司 | 突变体白介素-2多肽 |
| PT3134123T (pt) * | 2014-02-21 | 2021-03-22 | Nektar Therapeutics India Pvt Ltd | Agonistas seletivos de il-2rbeta em combinação com um anticorpo anti-ctla-4 ou um anticorpo anti-pd-1 |
| KR102493543B1 (ko) * | 2014-07-21 | 2023-01-30 | 데리니아, 인크. | 자가면역 질환의 치료를 위한 조절 t 세포를 선택적으로 활성화시키는 분자 |
| CN107148279B (zh) | 2014-10-21 | 2021-09-03 | 赛生药品股份国际有限公司 | 用免疫刺激剂治疗癌症 |
| IL304950A (en) * | 2015-04-10 | 2023-10-01 | Amgen Inc | Interleukin for the expansion of myotonic control T-2 cells |
| CN108136276B (zh) * | 2015-09-24 | 2023-02-28 | 韩美药品株式会社 | 通过使用免疫球蛋白片段的特异性位点进行连接的蛋白质复合物 |
| KR20240115933A (ko) * | 2016-05-04 | 2024-07-26 | 암젠 인크 | T-조절 세포의 증식을 위한 인터류킨-2 뮤테인 |
| EP3511340B1 (en) * | 2016-08-10 | 2024-10-02 | Ajou University Industry-Academic Cooperation Foundation | Heterodimeric fc-fused cytokine and pharmaceutical composition comprising the same |
| EP3538548A4 (en) * | 2016-11-08 | 2020-08-19 | Delinia, Inc. | IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
| KR102777151B1 (ko) * | 2017-11-21 | 2025-03-05 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 인터루킨-2의 부분 효능제 |
| US12565525B2 (en) * | 2018-03-28 | 2026-03-03 | Ascendis Pharma Oncology Division A/S | IL-2 conjugates |
| US12522640B2 (en) | 2018-07-24 | 2026-01-13 | BioNTech SE | IL2 agonists |
| CA3098930A1 (en) * | 2018-09-21 | 2020-03-26 | Innovent Biologics (Suzhou) Co., Ltd. | Novel interleukin-2 and use thereof |
| US20220025007A1 (en) * | 2018-12-21 | 2022-01-27 | Hanmi Pharm. Co., Ltd. | Novel immunosuppressive interleukin 2 |
| TW202115105A (zh) * | 2019-06-24 | 2021-04-16 | 德商拜恩迪克Ｒｎａ製藥有限公司 | Ｉｌ２激動劑 |
| CN114787182A (zh) * | 2019-08-13 | 2022-07-22 | 艾佩斯瑞生物制药公司 | 工程化的白细胞介素-2受体β激动剂 |
-
2022
- 2022-03-30 IL IL304365A patent/IL304365B2/en unknown
- 2022-03-31 BR BR112023018530A patent/BR112023018530A2/pt unknown
- 2022-03-31 AR ARP220100795A patent/AR125263A1/es unknown
- 2022-03-31 MX MX2023010926A patent/MX2023010926A/es unknown
- 2022-03-31 KR KR1020220040626A patent/KR102680146B1/ko active Active
- 2022-03-31 EP EP22781656.8A patent/EP4316528A4/en active Pending
- 2022-03-31 WO PCT/KR2022/004620 patent/WO2022211537A1/ko not_active Ceased
- 2022-03-31 US US18/000,096 patent/US12599675B2/en active Active
- 2022-03-31 AU AU2022209248A patent/AU2022209248B2/en active Active
- 2022-03-31 PE PE2023002484A patent/PE20250672A1/es unknown
- 2022-03-31 TW TW111112574A patent/TWI922649B/zh active
- 2022-03-31 CN CN202280017977.7A patent/CN116916969A/zh active Pending
- 2022-03-31 CA CA3205058A patent/CA3205058C/en active Active
- 2022-03-31 JP JP2023555563A patent/JP2024512418A/ja active Pending
-
2023
- 2023-07-19 ZA ZA2023/07219A patent/ZA202307219B/en unknown
- 2023-08-24 CL CL2023002504A patent/CL2023002504A1/es unknown
-
2024
- 2024-06-14 KR KR1020240077657A patent/KR20240099117A/ko active Pending